Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea · Delayed Price · Currency is KRW 972.00
-7.00 (-0.72%)
At close: Jun 5, 2026
Abpro Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -43,585 | -48,920 | -15,629 | -25,742 | -8,145 | -10,030 |
Depreciation & Amortization | 1,701 | 1,694 | 1,484 | 1,870 | 1,402 | 2,625 |
Loss (Gain) From Sale of Assets | 14.76 | 84.33 | -11,797 | 79.93 | -142.24 | -1,013 |
Asset Writedown & Restructuring Costs | 4,626 | 4,640 | 2,191 | 254.14 | - | 748.73 |
Loss (Gain) From Sale of Investments | 0.31 | 2.93 | -7.36 | 3,238 | -2,218 | 3,950 |
Loss (Gain) on Equity Investments | 29,031 | 33,300 | 27,881 | 9,377 | -4,219 | 5,876 |
Stock-Based Compensation | 250.93 | 282.62 | - | - | - | 260.5 |
Provision & Write-off of Bad Debts | -38.11 | -134.33 | -3,782 | 195.08 | -17.77 | -1,209 |
Other Operating Activities | 1,321 | 1,224 | -9,327 | 3,750 | 6,387 | -3,969 |
Change in Accounts Receivable | 4,143 | 6,432 | 1,676 | 133.03 | -488.08 | 2,519 |
Change in Inventory | 192.07 | 159.29 | 4,461 | 4,677 | -3,553 | 1,461 |
Change in Accounts Payable | -3,985 | -4,915 | -1,190 | -996.65 | -1,347 | 567.74 |
Change in Income Taxes | - | - | - | - | - | 0.01 |
Change in Other Net Operating Assets | -3,437 | -535.29 | -1,713 | -1,698 | -119.35 | -4,005 |
Operating Cash Flow | -9,765 | -6,686 | -5,752 | -4,862 | -12,461 | -2,220 |
Capital Expenditures | -1,599 | -1,915 | -17,109 | -1,148 | -132.25 | -542.24 |
Sale of Property, Plant & Equipment | 112.95 | 124.7 | 28,932 | 60.11 | 5.18 | 53.1 |
Cash Acquisitions | - | - | -9,986 | -7,155 | - | - |
Divestitures | - | - | - | - | - | 1,606 |
Sale (Purchase) of Intangibles | -361.71 | -212.56 | 1,193 | -1,090 | 1,347 | -3,244 |
Investment in Securities | 5,487 | 5,530 | -8,198 | 16,416 | -14,012 | -161 |
Other Investing Activities | 52.17 | -36.26 | 2,442 | 134.18 | -7,663 | 4,846 |
Investing Cash Flow | 5,414 | 2,463 | -6,788 | 5,633 | -21,352 | 8,348 |
Short-Term Debt Issued | - | 748 | 5,593 | - | - | - |
Long-Term Debt Issued | - | - | 17,240 | 6,900 | - | 14,616 |
Total Debt Issued | 491.27 | 748 | 22,833 | 6,900 | - | 14,616 |
Short-Term Debt Repaid | - | -1,443 | -5,677 | -150 | - | -56.83 |
Long-Term Debt Repaid | - | -6,676 | -8,582 | -5,572 | -3,373 | -236.25 |
Total Debt Repaid | -7,863 | -8,119 | -14,259 | -5,722 | -3,373 | -293.08 |
Net Debt Issued (Repaid) | -7,372 | -7,371 | 8,573 | 1,178 | -3,373 | 14,323 |
Issuance of Common Stock | 3,988 | - | - | - | - | 5,980 |
Repurchase of Common Stock | -12.07 | - | - | - | - | - |
Other Financing Activities | -19.4 | -19.4 | -0 | -0 | - | - |
Financing Cash Flow | -3,415 | -7,391 | 8,573 | 1,178 | -3,373 | 20,303 |
Foreign Exchange Rate Adjustments | 152.66 | 19.03 | 604.41 | -44.09 | 177.25 | 688.93 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | -7,613 | -11,595 | -3,362 | 1,905 | -37,009 | 27,120 |
Free Cash Flow | -11,365 | -8,601 | -22,861 | -6,011 | -12,593 | -2,762 |
Free Cash Flow Margin | -36.73% | -26.94% | -72.20% | -23.69% | -56.95% | -8.39% |
Free Cash Flow Per Share | -399.06 | -302.12 | -784.09 | -216.00 | -469.40 | -102.45 |
Cash Interest Paid | 927.59 | 987.68 | 628.37 | 417.18 | 397.92 | 400.65 |
Cash Income Tax Paid | - | -0.92 | -0.05 | 138.89 | -34.96 | 130.45 |
Levered Free Cash Flow | -8,071 | -7,144 | -19,266 | -6,703 | -6,719 | -12,719 |
Unlevered Free Cash Flow | -7,369 | -6,288 | -17,960 | -5,240 | -3,849 | -8,432 |
Change in Working Capital | -3,086 | 1,141 | 3,235 | 2,115 | -5,508 | 542.37 |